BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 10655152)

  • 1. Molecular genetics and mechanism of autosomal dominant polycystic kidney disease.
    Wu G; Somlo S
    Mol Genet Metab; 2000 Jan; 69(1):1-15. PubMed ID: 10655152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2).
    Boucher C; Sandford R
    Eur J Hum Genet; 2004 May; 12(5):347-54. PubMed ID: 14872199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations of PKD1 in ADPKD2 cysts suggest a pathogenic effect of trans-heterozygous mutations.
    Watnick T; He N; Wang K; Liang Y; Parfrey P; Hefferton D; St George-Hyslop P; Germino G; Pei Y
    Nat Genet; 2000 Jun; 25(2):143-4. PubMed ID: 10835625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genes homologous to the autosomal dominant polycystic kidney disease genes (PKD1 and PKD2).
    Veldhuisen B; Spruit L; Dauwerse HG; Breuning MH; Peters DJ
    Eur J Hum Genet; 1999 Dec; 7(8):860-72. PubMed ID: 10602361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity in renal and hepatic epithelial cystic cells from ADPKD1 patients.
    Badenas C; Torra R; Pérez-Oller L; Mallolas J; Talbot-Wright R; Torregrosa V; Darnell A
    Eur J Hum Genet; 2000 Jul; 8(7):487-92. PubMed ID: 10909847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haploinsufficiency of Pkd2 is associated with increased tubular cell proliferation and interstitial fibrosis in two murine Pkd2 models.
    Chang MY; Parker E; Ibrahim S; Shortland JR; Nahas ME; Haylor JL; Ong AC
    Nephrol Dial Transplant; 2006 Aug; 21(8):2078-84. PubMed ID: 16720597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mutational analysis of the PKD1 and PKD2 (type 1 and 2 dominant autosomal polycystic kidney) genes].
    Torra R; Badenas C; Pérez-Oller L; San Millán JL; Tellería D; Estivill X; Darnell A
    Nefrologia; 2000; 20(1):39-46. PubMed ID: 10822721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathogenesis of cystic kidney diseases].
    Walz G
    Verh Dtsch Ges Pathol; 2002; 86():138-44. PubMed ID: 12647363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PKD1 and PKD2 mutations in Slovenian families with autosomal dominant polycystic kidney disease.
    Vouk K; Strmecki L; Stekrova J; Reiterova J; Bidovec M; Hudler P; Kenig A; Jereb S; Zupanic-Pajnic I; Balazic J; Haarpaintner G; Leskovar B; Adamlje A; Skoflic A; Dovc R; Hojs R; Komel R
    BMC Med Genet; 2006 Jan; 7():6. PubMed ID: 16430766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PKD2 mutations in a Czech population with autosomal dominant polycystic kidney disease.
    Stekrová J; Reiterová J; Merta M; Damborsky J; Zidovská J; Kebrdlová V; Kohoutová M
    Nephrol Dial Transplant; 2004 May; 19(5):1116-22. PubMed ID: 14993477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-inheritance of a PKD1 mutation and homozygous PKD2 variant: a potential modifier in autosomal dominant polycystic kidney disease.
    Dedoussis GV; Luo Y; Starremans P; Rossetti S; Ramos AJ; Cantiello HF; Katsareli E; Ziroyannis P; Lamnissou K; Harris PC; Zhou J
    Eur J Clin Invest; 2008 Mar; 38(3):180-90. PubMed ID: 18257781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical, genetic and molecular studies on autosomal dominant polycystic kidney disease].
    Torra R; Badenas C; Darnell A; Nicolau C; Volpini V; Revert L; Estivill X
    Med Clin (Barc); 1998 Apr; 110(13):481-7. PubMed ID: 9611728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Heterozygosity loss and somatic mutations in type I and II dominant autosomal renal polycystic kidney disease: evidence of a recessive mechanism at a cell level in cystogenesis].
    Pérez-Oller L; Torra R; Badenas C; San Millán JL; Darnell A
    Nefrologia; 2000; 20(2):130-8. PubMed ID: 10853193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation analysis in PKD1 of Japanese autosomal dominant polycystic kidney disease patients.
    Inoue S; Inoue K; Utsunomiya M; Nozaki J; Yamada Y; Iwasa T; Mori E; Yoshinaga T; Koizumi A
    Hum Mutat; 2002 Jun; 19(6):622-8. PubMed ID: 12007219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current advances in molecular genetics of autosomal-dominant polycystic kidney disease.
    Wu G
    Curr Opin Nephrol Hypertens; 2001 Jan; 10(1):23-31. PubMed ID: 11195048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of PKD1 causes polycystic kidney disease.
    Thivierge C; Kurbegovic A; Couillard M; Guillaume R; Coté O; Trudel M
    Mol Cell Biol; 2006 Feb; 26(4):1538-48. PubMed ID: 16449663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotypes of autosomal dominant polycystic kidney disease in Japanese.
    Mizoguchi M; Tamura T; Yamaki A; Higashihara E; Shimizu Y
    J Hum Genet; 2002; 47(1):51-4. PubMed ID: 11829141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents.
    Hanaoka K; Qian F; Boletta A; Bhunia AK; Piontek K; Tsiokas L; Sukhatme VP; Guggino WB; Germino GG
    Nature; 2000 Dec 21-28; 408(6815):990-4. PubMed ID: 11140688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular polycystins: insights from autosomal dominant polycystic kidney disease and transgenic animal models.
    Bichet D; Peters D; Patel AJ; Delmas P; Honoré E
    Trends Cardiovasc Med; 2006 Nov; 16(8):292-8. PubMed ID: 17055386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PKD1 interacts with PKD2 through a probable coiled-coil domain.
    Qian F; Germino FJ; Cai Y; Zhang X; Somlo S; Germino GG
    Nat Genet; 1997 Jun; 16(2):179-83. PubMed ID: 9171830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.